Easywell Biomedicals, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 271.63 million compared to TWD 178.9 million a year ago. Net loss was TWD 144.82 million compared to TWD 161 million a year ago.

Basic loss per share from continuing operations was TWD 1.27 compared to TWD 1.41 a year ago.